174 related articles for article (PubMed ID: 24660566)
1. An unusual case of invasive Aspergillus ulcerative tracheobronchitis without involvement of lung parenchyma in a post-renal transplant patient.
Tilve SS; Shah AB; Prabhudesai PP; Tampi C
Indian J Chest Dis Allied Sci; 2013; 55(4):221-3. PubMed ID: 24660566
[TBL] [Abstract][Full Text] [Related]
2. [Aspergillus tracheobronchitis in a lung transplant recipient].
García-Gallo CL; García-Fadul C; Laporta-Hernández R; Ussetti-Gil P
Rev Iberoam Micol; 2011; 28(3):129-33. PubMed ID: 21700233
[TBL] [Abstract][Full Text] [Related]
3. Aspergillus thyroiditis in a renal transplant recipient mimicking subacute thyroiditis.
Solak Y; Atalay H; Nar A; Ozbek O; Turkmen K; Erekul S; Turk S
Transpl Infect Dis; 2011 Apr; 13(2):178-81. PubMed ID: 20738834
[TBL] [Abstract][Full Text] [Related]
4. Ulcerative tracheobronchitis due to Aspergillus.
Dominelli GS; Shaipanich T
J Bronchology Interv Pulmonol; 2013 Oct; 20(4):326-9. PubMed ID: 24162116
[TBL] [Abstract][Full Text] [Related]
5. Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
Damaj G; Ivanov V; Le Brigand B; D'incan E; Doglio MF; Bilger K; Faucher C; Vey N; Gastaut JA
Ann Hematol; 2004 Jun; 83(6):390-3. PubMed ID: 14666380
[TBL] [Abstract][Full Text] [Related]
6. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis.
Kramer MR; Denning DW; Marshall SE; Ross DJ; Berry G; Lewiston NJ; Stevens DA; Theodore J
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):552-6. PubMed ID: 1654038
[TBL] [Abstract][Full Text] [Related]
7. Radiological resolution of cavitating Aspergillus fumigatus infection following treatment with oral voriconazole in two lung transplant recipients.
Zoumot Z; Carby M; Hall AV
Transpl Int; 2006 Aug; 19(8):688-90. PubMed ID: 16827687
[No Abstract] [Full Text] [Related]
8. Ulcerative pseudomembranous tracheobronchitis caused by Aspergillus fumigatus.
Ariza-Prota M; Morales-Soto A; Rosell-Grataços A
Arch Bronconeumol; 2016 Aug; 52(8):436-7. PubMed ID: 26497417
[No Abstract] [Full Text] [Related]
9. Voriconazole in the treatment of invasive aspergillosis in kidney transplant recipients.
Veroux M; Corona D; Gagliano M; Sorbello M; Macarone M; Cutuli M; Giuffrida G; Morello G; Paratore A; Veroux P
Transplant Proc; 2007; 39(6):1838-40. PubMed ID: 17692627
[TBL] [Abstract][Full Text] [Related]
10. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
Singh N; Limaye AP; Forrest G; Safdar N; Muñoz P; Pursell K; Houston S; Rosso F; Montoya JG; Patton P; Del Busto R; Aguado JM; Fisher RA; Klintmalm GB; Miller R; Wagener MM; Lewis RE; Kontoyiannis DP; Husain S
Transplantation; 2006 Feb; 81(3):320-6. PubMed ID: 16477215
[TBL] [Abstract][Full Text] [Related]
11. Late aspergilloma of a renal allograft without need for operative management: a case report and review of the literature.
Shannon EM; Reid MJ; Chin-Hong P
Transpl Infect Dis; 2016 Apr; 18(2):261-5. PubMed ID: 26751414
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
13. Economic evaluation of voriconazole versus caspofungin for the treatment of invasive aspergillosis in Belgium.
Selleslag D; Vogelaers D; Marbaix S
Acta Clin Belg; 2009; 64(5):393-8. PubMed ID: 19999386
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L
Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338
[TBL] [Abstract][Full Text] [Related]
15. Pseudomembranous tracheobronchitis caused by Aspergillus in immunocompromised patients.
Chang SM; Kuo HT; Lin FJ; Tzen CY; Sheu CY
Scand J Infect Dis; 2005; 37(11-12):937-42. PubMed ID: 16308239
[TBL] [Abstract][Full Text] [Related]
16. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole.
Neoh CF; Leung L; Vajpayee RB; Stewart K; Kong DC
Ann Pharmacother; 2011 May; 45(5):e24. PubMed ID: 21521864
[TBL] [Abstract][Full Text] [Related]
18. Report of 38 cases of tracheobronchitis in non-immunocompromised patients with dual isolation of Aspergillus in lower respiratory tract samples.
Barberán J; Sánchez-Haya E; del Castillo D; Sanz F; Alcázar B; Malmierca E;
Rev Esp Quimioter; 2014 Jun; 27(2):110-4. PubMed ID: 24940892
[TBL] [Abstract][Full Text] [Related]
19. [Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].
Gasch O; Fernández N; Ayats J; Santin M
Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):193-4. PubMed ID: 19306722
[No Abstract] [Full Text] [Related]
20. Pseudomembranous and obstructive Aspergillus tracheobronchitis - optimal diagnostic strategy and outcome.
Tasci S; Glasmacher A; Lentini S; Tschubel K; Ewig S; Molitor E; Sauerbruch T; Lüderitz B; Rabe C
Mycoses; 2006 Jan; 49(1):37-42. PubMed ID: 16367817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
